The proposal outlines experiments designed to test the proposition that cells can be protected from HIV infection by programming them to synthesize protective macromolecules. We term this,intracellular immunization. Our major hope is that the expression of anti-sense RNA's will protect cells by either preventing total reverse transcription of the viral genome or expression of integrated viral genomes. Another possibility is that a small sense RNA representing the 5' end of viral RNA will be effective because it will compete with tat-responsive sequence element, TAR. Another possibility is that viral proteins, particularly the glycoprotein will be inhibitory. This is conceptually quite separate from the other parts of this grant but brings to the consortium particular technical strengths and balances and approach to protection of the population against HIV.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
076580745
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Segal, A H (1996) Anatomic predilection of the spondyloarthropathies(-)a case of the nerves? J Rheumatol 23:491-4
Burns, D P; Collignon, C; Desrosiers, R C (1993) Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys. J Virol 67:4104-13
Burns, D P; Desrosiers, R C (1992) A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays. AIDS Res Hum Retroviruses 8:1189-92
Javaherian, K; Langlois, A J; Schmidt, S et al. (1992) The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 89:1418-22
Kim, S; Ikeuchi, K; Groopman, J et al. (1990) Factors affecting cellular tropism of human immunodeficiency virus. J Virol 64:5600-4
Kim, S; Ikeuchi, K; Byrn, R et al. (1989) Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 86:9544-8